Characterization of effects of a neurotropic murine coronavirus infection on Alzheimer's disease neuropathology of 5xFAD mice

1. Problem Statement

Alzheimer's Disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta (Aβ) plaque deposition and neurofibrillary tangles. Recent epidemiological data suggests a strong association between viral encephalitis and an increased risk of developing AD. However, the specific molecular and cellular mechanisms by which acute viral-induced neuroinflammation interacts with established AD pathology (specifically Aβ plaques) remain poorly understood. While previous studies have explored viral risks, there is a lack of high-resolution data on how viral infection alters the transcriptional state of myeloid cells (microglia and infiltrating macrophages) in the context of existing amyloid burden.

2. Methodology

The study utilized a multi-modal approach combining viral infection models, histology, flow cytometry, bulk RNA sequencing, and advanced spatial transcriptomics.

• Animal Model: Aged (10-month) and young (6-month) 5xFAD mice (a model of familial AD with high Aβ burden) and Wild-Type (WT) C57BL/6 mice were used.
• Viral Infection: Mice were intracranially inoculated with 500 PFU of the JHM strain of murine hepatitis virus (JHMV), a neurotropic coronavirus that induces acute encephalomyelitis. Control groups received vehicle (HBSS).
• Timepoints: Analysis was conducted primarily at 12 days post-infection (p.i.), with additional bulk RNA sequencing at 7 and 14 days p.i.
• Histopathology & Biochemistry:
  • Immunohistochemistry: Staining for Aβ (Amylo-Glo, 6E10, OC), viral antigens (JHMV nucleocapsid), and immune markers (MAC2/Lgals3, CD4, CD8, IBA1).
  • Biochemical Assays: Quantification of soluble and insoluble Aβ40/42 via Meso Scale Discovery (MSD) ELISA and plasma Neurofilament Light chain (NfL) levels.
  • Demyelination: Luxol Fast Blue (LFB) staining of spinal cords.
• Flow Cytometry: Quantification of CNS-infiltrating CD4+ and CD8+ T cells and myeloid populations (CD45hiCD11b+ vs. CD45loCD11b+).
• Transcriptomics:
  • Bulk RNA-seq: Performed on whole hemi-brains at 7 and 14 days p.i. to identify global pathway changes.
  • Spatial Transcriptomics: Utilized the Bruker Nanostring CosMx Spatial Molecular Imager (SMI) with a 1000-plex mouse neuroscience panel. This allowed for single-cell resolution gene expression profiling while retaining spatial context (cortex, hippocampus, subiculum) across 12 brain sections.
• Data Analysis: Differential Gene Expression (DGE) analysis, Gene Ontology (GO) pathway enrichment, and pseudo-bulk analysis of specific cell clusters (e.g., Disease-Associated Microglia - DAM).

3. Key Contributions

• Integration of Viral and AD Models: The study provides a comprehensive characterization of how acute viral encephalitis impacts established amyloid pathology in a pre-clinical AD model.
• Spatial Transcriptomics in AD/Viral Context: It is one of the first studies to apply high-plex spatial transcriptomics to dissect the interaction between viral-induced inflammation and Aβ plaques at the single-cell level, moving beyond bulk tissue analysis.
• Identification of a "Dampened" DAM Response: The study reveals a paradoxical finding where viral infection, despite increasing myeloid cell infiltration, suppresses the specific Disease-Associated Microglia (DAM) transcriptional program typically associated with Aβ clearance.

4. Key Results

A. Clinical and Viral Control

• JHMV infection caused significant weight loss and motor impairment in both WT and 5xFAD mice, though 5xFAD mice showed slightly less weight loss.
• Viral replication levels (RNA load) were similar between WT and 5xFAD mice, indicating that AD pathology did not significantly alter viral control.
• Viral RNA and antigen persisted in white matter tracts (brainstem, subiculum) and induced significant demyelination in the spinal cord, particularly in 5xFAD mice.

B. Impact on Aβ Plaque Pathology

• Total Aβ Burden: Biochemical analysis (soluble/insoluble Aβ40/42) and staining for fibrillar Aβ (OC) showed no significant change in total Aβ load.
• Plaque Morphology: Amylo-Glo staining revealed a significant reduction in the volume and number of dense-core Aβ plaques in the subiculum and somatosensory cortex of infected 5xFAD mice.
• Correlation: This reduction correlated with regions of high viral persistence and high infiltration of MAC2+ (Lgals3+) macrophages.

C. Immune Cell Infiltration

• T Cells: Significant infiltration of CD4+ and CD8+ T cells occurred in the CNS by day 12. Interestingly, T cell infiltration was lower in 5xFAD mice compared to WT, despite similar viral loads.
• Myeloid Cells: There was a massive recruitment of peripheral MAC2+ monocyte-derived macrophages to the brain, particularly surrounding dense-core plaques.

D. Spatial Transcriptomics & Gene Expression

• Myeloid Cell Shifts: While the proportion of myeloid cells increased, their transcriptional profile changed drastically.
• Suppressed DAM Signature: In JHMV-infected 5xFAD brains, myeloid cells showed downregulation of key DAM genes (e.g., Trem2, Cd9, Clec7a, Ctsd, Apoe) that are typically upregulated in response to Aβ plaques.
• Unique Interaction: A specific set of 143 genes was uniquely dysregulated only when both amyloid pathology and viral encephalitis were present. This included the downregulation of phagocytic markers (Lyz1/2, Tyrobp) and upregulation of antigen presentation genes (H2-Aa, Cd74).
• Sub-clustering: The study identified two distinct DAM sub-clusters (DAM-1 and DAM-2). DAM-2 cells, characterized by high expression of Itgax, Spp1, Gpnmb, were more prevalent in infected 5xFAD brains and appeared in direct contact with dense-core plaques, suggesting a shift in the functional phenotype of plaque-associated myeloid cells.

5. Significance and Conclusion

• Mechanistic Insight: The findings suggest that acute viral encephalitis does not simply "add" inflammation to AD but fundamentally alters the functional response of myeloid cells to amyloid pathology. Specifically, the virus appears to induce a state where myeloid cells infiltrate the brain but fail to mount a full DAM response, potentially impairing Aβ clearance mechanisms despite the physical compaction of plaques.
• Risk Factor Implications: This supports the hypothesis that viral infections act as a modulating risk factor for AD, potentially accelerating neurodegeneration by dysregulating the neuroimmune response to amyloid rather than just increasing plaque load.
• Therapeutic Relevance: The study highlights the complexity of targeting neuroinflammation in AD. Therapies aimed at boosting myeloid activity must consider that viral infections might paradoxically suppress specific protective myeloid pathways (DAM) while driving others (antigen presentation).
• Future Directions: The authors note the need to investigate the long-term consequences of this "dampened" response on tau pathology and neuronal loss, as well as the use of humanized mouse models to better translate these findings to human AD.

In summary, this paper demonstrates that while viral encephalitis reduces the physical size of dense-core Aβ plaques via macrophage infiltration, it simultaneously disrupts the critical transcriptional programs (DAM) required for effective amyloid clearance, potentially exacerbating the underlying neurodegenerative process.